Throughout their evolution, animals have engaged in a continual struggle with potential parasites. Avoidance of infection by microbial and multicellular pathogens is probably extremely important in determining the success of individuals and species, so most animals have developed an array of mechanisms to prevent infection. Vertebrates have developed mechanisms to identify and destroy foreign biological material within their own bodies.
These systems for excluding 'non-self' organisms and maintaining the integrity of the 'self' have accumulated over evolutionary time until they now constitute one of the most complex of all body systems, the immune system. The immune system of modern animals is the highly developed product of hundreds of millions of years of conflict between potential host and potential parasite. Although the exact biological mechanisms involved in the immune response vary across the animal kingdom, the principle of excluding 'non-self' material to protect the 'self' is extremely widespread (Horton and Ratcliffe, 1993) .
The mammalian immune system was probably well established by the time the metatherian (marsupial) and eutherian ('placental') lineages diverged approximately 100 million years ago, and ancestral eutherians were almost certainly able to detect and remove invading parasitic organisms. However, with the evolution of longer pregnancies in eutherians, their reproductive and immune systems came into potential conflict. Evolution of the placenta to allow female mammals to maintain fetuses within the reproductive tract for prolonged periods presented them with a considerable immunological challenge. All mammalian fetuses inherit almost half of their genes from their father and, because of this, the placenta is a site at which the mother can be exposed to 'non-self' paternal antigens. Expression of foreign molecules on a tissue would usually lead to rejection of that tissue by the immune system, and so preventing rejection of the placenta was a necessity during the evolution of eutherian mammals.
The immunological predicament of the eutherian fetus was complicated by a further factor: mammalian mothers and fetuses are continually exposed to a range of potential pathogens. Because of this, any mechanism the fetus uses to avoid rejection by its mother is constrained by a need for them both to be able to fend off invading organisms. For example, the fetus cannot ensure its own survival by a generalized suppression of the maternal immune system, as this would lay both mother and fetus open to overwhelming infection. Similarly, methods used by the fetus to inform the maternal immune system that it is benign might be reproduced by a pathogen, with disastrous results.
This review describes how eutherian mammals are thought to have addressed the immunological problems associated with protracted pregnancy: how does the fetus avoid being treated like a parasite or a tissue transplant? First, it will be explained why the foreignness of a fetus is most likely to be betrayed to its mother by the products of a small set of genes, the major histocompatibility complex (MHC) genes. Second, it will be described how fetuses of different groups of mammals control trophoblast MHC expression to avoid maternal immune attack. Finally, the potential for this comparative approach to explain how pregnancy is maintained in the presence of maternal immunity is discussed.
Transplantation antigens and the major histocompatibility complex
The study of the immunological status of the mammalian fetus has been primarily directed towards determining which MHC Eutherian mammals have inherited a typical vertebrate immune system, which protects the body against infectious organisms by detecting and destroying foreign biological material. However, with the evolution of longer gestation periods, this protective mechanism became a potential threat to the 'semi-foreign' fetus and so eutherians have developed systems to prevent immune rejection of their developing fetuses. In many species, this is achieved by reducing placental expression of major histocompatibility complex (MHC) genes, the products of which are responsible for most transplantation rejection reactions. Unexpectedly, however, major histocompatibility complex expression is often re-established in the most invasive trophoblast cells. It is not known why transplantation antigen expression in the fetal cells most exposed to the maternal immune system is advantageous. It is possible that such expression aids the process of invasion or exerts an immunoprotective effect on the fetus. It may prove possible to identify the essential steps that all eutherian fetuses take to ensure their survival in the face of potential maternal immune attack by studying the common features of the placental immunology of different species.
molecules are expressed on trophoblast cells, and there is an important reason for this: a disproportionately large number of transplant rejection reactions are directed against a few products encoded by the MHC genetic region. This tendency for foreign MHC products to induce immune responses is borne out by the finding that most maternal antibodies generated against the fetus during pregnancy are directed against paternally inherited MHC (Antczak, 1989) . Therefore, immunologists have tried to find out whether the placenta evades immune rejection by reducing expression of these immunologically provocative molecules. Early studies (reviewed by Klein, 1975) led to the discovery that rejection or acceptance of tissue grafts in mice was largely controlled by the degree of similarity among a few proteins on the cells of donor and recipient animals. The genes encoding these proteins were found to be inherited en bloc in a simple Mendelian codominant fashion, and this finding has been explained subsequently by the co-location of these genes within a small region of a single chromosome. This single genetic region containing all the most important genes for tissue graft compatibility ('major histocompatibility') has since been shown to be common to most vertebrate species (Kaufmann, 1996) .
The transplantation antigens encoded by the MHC have three important features that explain their central role in the process of tissue graft rejection. First, a subset of these molecules, called classical class I MHC, is expressed on almost all nucleated cells in the mammalian body. Because of this, almost any transplanted tissue will bear class I molecules to which a recipient can react. Second, the classical MHC genes and proteins are usually extremely variable or 'polymorphic' within mammalian populations. Powerful selective forces act to maintain many different alleles of some class I genes in outbred populations, and this explains why randomly selected graft donor-recipient pairs are usually MHC-discordant at most MHC loci (Bodmer, 1972; Browning and Krausa, 1996) .
The third reason for the effectiveness of MHC molecules in inducing tissue graft rejection is that they are directly involved in the differentiation of 'non-self' from 'self'. The pioneering work of Zinkernagel and Doherty (1974) , demonstrating that the immune system does not detect foreign antigens in isolation but recognizes them when they are carried by MHC molecules, laid the foundations of our understanding of the function of the MHC. It is now known that MHC-encoded proteins are the molecules that cells use to present material to the immune system and this is why lymphocytes recognize complexes of foreign antigen with 'self' MHC. This mechanism explains why the immune system reacts so markedly to foreign MHC on tissue grafts: every time recipient lymphocytes bind to donor cells, they bind to its MHC antigens and identify them as foreign.
The antigen-presenting role of class I MHC is reflected in its structure and cellular interactions. Mature class I MHC is present on the cell surface as a complex containing (i) a polymorphic MHC-encoded 44 kDa heavy chain glycoprotein, (ii) a monomorphic non-MHC-encoded 12 kDa light chain, called β 2 -microglobulin, and (iii) a short peptide, usually a nonamer. This short peptide is a fragment of a larger protein that the cell has cleaved for presentation to the immune system, and it is bound in a cleft in the class I heavy chain (Bjorkman et al., 1987; Falk et al., 1991) .
Classical class I molecules are thought to undergo two main interactions with cells of the immune system ( Fig. 1) . First, if MHC on body cells presents foreign peptides, then it may activate cytotoxic T lymphocytes. This interaction is thought to be central to the induction of immune responses to intracellular pathogens. Second, the presence of class I MHC on cells can suppress the activity of natural killer cells and render the cell resistant to natural killer attack. This process may be involved in tumour surveillance by the immune system, since an important function of natural killer cells may be to destroy neoplastic cells, which exhibit reduced MHC expression (Lanier and Phillips, 1996) .
Thus, MHC class I is the master molecule of tissue compatibility because it is ubiquitous, polymorphic and involved in many immune interactions. A knowledge of the function of class I MHC in transplantation, infection and neoplasia is essential to develop an understanding of how the mammalian fetus has attained its privileged immunological status. While MHC expression could be a potential liability for the fetus, the protection it confers must not be underestimated. How have different mammalian fetuses retained the advantages of the MHC without causing a catastrophic rejection response by their mother?
Transplantation antigen expression on mammalian trophoblast
Long before the structure and function of MHC molecules was elucidated, the potential risk that they pose to eutherian fetuses was recognized. Medawar (1953) proposed three possible strategies for minimizing this risk and these remain the foundation of placental immunology today: (1) the fetus may reduce or modify transplantation antigen expression on trophoblast; (2) the fetus may modulate the maternal immune system to protect itself from recognition or attack; or (3) the placenta may present a barrier on which and through which maternal immune effector mechanisms cannot act.
There is now evidence that all three of these processes occur to different extents in different species, but most research effort has been directed at investigating the first strategy, and it is trophoblast MHC expression on which the rest of this review will focus. Mammals exhibit many ways of modulating MHC expression on trophoblast, but certain common features emerge which give us an insight into the fundamental immunological challenge facing the eutherian fetus, and the essential steps it takes to meet that challenge.
It has proved extremely difficult to establish a firm taxonomy for eutherian mammals (Novacek, 1982) , but the possible evolutionary relationships between the major eutherian taxonomic groups is illustrated and the species in which trophoblast MHC expression has been investigated are highlighted (Fig. 2) .
Human trophoblast
Trophoblast transplantation antigen expression has been most thoroughly examined in humans, due largely to the availability of a wide range of reagents that discriminate between the different human MHC (human leukocyte antigen, HLA) products HLA-A, -B, -C, -E and -G.
Early studies (Redman et al., 1984) indicated that human trophoblast cells do not express the two main polymorphic classical class I antigens HLA-A and -B (Fig. 3) . While this finding indicated that downregulation of transplantation antigens might explain the apparent resistance of the fetus to maternal immune detection, it was accompanied by the intriguing finding that some trophoblast subsets express an additional, unidentified class I molecule. This non-classical molecule was characterized as a truncated MHC class I (Ellis et al., 1986) , its cDNA and gene sequence were published (Geraghty et al., 1987; Ellis et al., 1990) and it was allocated the name HLA-G.
HLA-G exhibits features that indicate that it plays an important and unusual role in maintaining the fetomaternal interface. First, HLA-G protein expression is restricted almost entirely to trophoblast cells relatively exposed to the maternal immune system: the extravillous cytotrophoblast, which invades the decidua and lines the maternal blood spaces, and the chorionic cytotrophoblast, which constitutes the outermost fetal membrane. Apart from in the thymus (Crisa et al., 1997) , there is no conclusive evidence that HLA-G is expressed anywhere else in the human body and, thus, HLA-G is unique in exhibiting a reciprocal pattern of tissue expression to that of classical HLA-A and -B (Fig. 3) .
A second unusual characteristic of HLA-G which is in direct contrast to classical MHC class I is that it is almost entirely nonpolymorphic at the genetic and protein levels (Kovats et al., 1990; Bainbridge et al., 1999a) . While multiple allelic variants of HLA-A and -B have been maintained in the human population, HLA-G is present in very few forms. The implications of this for the function of HLA-G in pregnancy are extremely important since the lack of variation in HLA-G means that paternally inherited HLA-G expressed on trophoblast will be identical, or extremely similar, to the HLA-G of the mother. Thus, expression of this special 'placental' class I molecule may allow the fetus to carry out some or all of the functions of MHC Gestation (days) Placental type Fig. 2 . Summary of the possible evolutionary relationships among major eutherian taxonomic groups. Groups are colour-coded according to their tendencies to undergo short (< 50 days, blue), intermediate (50-100 days, green) or long (> 100 days, red) pregnancies. Trophoblast MHC expression is well studied only in some primates, rodents, artiodactyls (even-toed ungulates) and perissodactyls (odd-toed ungulates) and, for these species, details of gestation duration and placental morphology are given.
class I without any risk of inducing a transplant-like rejection reaction from its mother. Indeed, there is evidence that human mothers are exposed to paternally inherited HLA-G because the gene is not imprinted in trophoblast (Bainbridge et al., 1999a) . A third unusual feature of HLA-G is that its mRNA is alternatively spliced to yield a transcript predicted to encode a soluble form of HLA-G (Fujii et al., 1994) which may be shed from the placenta into the maternal circulation. The presence of this molecule in maternal blood has not been conclusively demonstrated, but soluble HLA-G may represent a way in which the fetus can exert effects on distant elements of the maternal immune system.
The functions of HLA-G in pregnancy are gradually becoming apparent (Le Bouteiller and Blaschitz, 1999) . Although it is slightly shorter than classical class I molecules, HLA-G is thought to adopt a similar structure to HLA-A and -B. HLA-G is known to bind both peptide and β 2 -microglobulin (Ellis et al., 1986; Lee et al., 1995) and interacts with the same lymphocyte subsets as classical class I molecules. HLA-G is known to bind the cluster determinant antigen, CD8 (Sanders et al., 1991) , but there is also evidence that soluble HLA-G induces apoptosis in cytotoxic T cells, the reverse of the stimulatory effects of membrane bound HLA-A and -B (Fournel et al., 1999) . HLA-G expression reduces cellular susceptibility to natural killer attack (Pazmany et al., 1996) , although this effect may be mediated indirectly by another molecule, HLA-E (Braud et al., 1997) .
Apart from HLA-G, there are two other MHC class I molecules expressed on human trophoblast, although neither of them is restricted to placental cells in the same way as HLA-G. HLA-E is another non-classical class I molecule, and its most striking feature is the extremely limited range of peptides it is able to carry (Braud et al., 1997) . Because of this, HLA-E is unlikely to act as a conventional peptide presenter and there is evidence that it may simply protect trophoblast cells against natural killer attack (Braud et al., 1998) . The other MHC molecule present on trophoblast is HLA-C ( King et al., 1996) but the status of this molecule is unclear. Like classical class I molecules, HLA-C is not truncated and its genetic locus is polymorphic, albeit less so than the loci of HLA-A and -B. However, HLA-C is expressed at a far lower concentration than HLA-A and -B in extraplacental tissues or HLA-G in trophoblast. In addition, it is not known to what extent HLA-C participates in peptide presentation. It is possible that HLA-C is also involved in protecting trophoblast from natural killer cells.
Thus, human trophoblast cells exhibit an extremely unusual pattern of transplantation antigen expression, bearing the invariant HLA-G molecule instead of highly polymorphic HLA-A and -B. Are humans representative of eutherian mammals in this respect, or have other species developed different patterns of placental MHC expression to avoid immune rejection of the fetus?
Non-human primates
Although they are the closest relatives of humans, there is little published information on trophoblast immunology of the great apes. Some MHC genes have been characterized in chimpanzees (Pan troglodytes) and gorillas (Gorilla gorilla) and it appears that both these species have expressible homologues of the HLA-G gene (Lawlor et al., 1988 (Lawlor et al., , 1990 . As yet, there is no evidence to indicate that trophoblast MHC expression in chimpanzees and gorillas is very different from that of humans.
Recent studies of an Old World monkey, the rhesus monkey (Macaca mulatta), have provided several interesting insights into comparative placental immunology. A highly conserved homologue of HLA-G, Mamu-G, has been described in rhesus monkeys, but it is inactivated by the insertion of a premature stop codon (Boyson et al., 1996) , indicating that placental expression of HLA-G homologues is not a general feature of pregnancy in mammals, or even primates. However, there is evidence that the role of the HLA-G gene may be carried out in rhesus monkeys by a different gene, Mamu-AG, thought to be more closely related to HLA-A than HLA-G (Boyson et al., 1997) . Despite the distant evolutionary relationship of Mamu-AG with HLA-G, the similarities between the two loci are remarkable. Mamu-AG exhibits limited polymorphism, its protein product is slightly shorter than classical MHC class I molecules and it is expressed in invasive extravillous cytotrophoblast (Slukvin et al., 1998 (Slukvin et al., , 1999 . Thus, while HLA-G homologues may not be necessary for pregnancy, distantly related MHC genes may be able to take over their function. These studies in rhesus monkeys indicate that non-polymorphic, truncated class I molecules may be a common feature of the placenta in primates, although they are not always encoded by the same locus.
Information on MHC genes in New World primates has extended our knowledge of the evolution of HLA-G in a novel direction. Like humans, New World primates express classical class I genes in most tissues of the body, probably to present peptide to T lymphocytes and suppress natural killer cells. Surprisingly, most classical class I genes in these species appear to be more closely related to HLA-G than to human classical class I genes (Cadavid et al., 1997) . Indeed, most species express only HLA-G homologues, and no other classical class I. These findings demonstrate several features of the evolution of human placental HLA-G. First, HLA-G is an ancient evolutionary entity, having existed as a discrete locus since the divergence of Old World and New World primates. Second, not only is trophoblast expression of non-classical HLA-G not a general feature of pregnancy in primates, but also HLA-G homologues can act as classical class I molecules in non-humans. Thus, HLA-G is not an inherently 'placental' gene in the evolutionary sense. Probably it is the pattern of expression of HLA-G and its lack of polymorphism that are important for its function in humans, rather than the locus from which it is derived or even the sequence of the mature protein.
Before leaving the primates, it is important to note the lack of information on placental immunology of prosimian primates. This is unfortunate not simply because they are our 'nextclosest' relatives, but because they have a very different placental morphology. New World and Old World monkeys exhibit haemochorial placentation, in which the maternal side of the placenta is eroded away by invading trophoblast. In contrast (Fig. 4) , most prosimian primates have epitheliochorial placentas in which more placental layers persist throughout pregnancy. It is likely that the degree of erosion of the maternal side of the placenta has marked effects on the exposure of the maternal immune system to fetal antigens. Thus, prosimian primates are an untapped resource: a closely related group of animals with a fundamentally different mode of placentation. It would be instructive to know how their solution to the problem of the immune status of the prosimian fetus differs from that of humans.
Rodents
Other than the primates, the only groups of eutherian mammals in which placental immunology has been studied in detail are the rodents, perissodactyls and artiodactyls (Fig. 2) . Interpreting the differences between these groups and higher primates is complicated by the fact that none of them exhibit long-term haemochorial placentation. For example, rodent species with short pregnancies may not need a highly developed mechanism for the fetus to evade maternal immune detection, as it may be immunologically simpler to maintain a mouse placenta for 14 days than a human placenta for 260 days. Similarly, it is likely that ungulate trophoblast cells, separated from maternal immune cells by three layers of tissue, are less at risk than human trophoblast cells, which are in direct contact with maternal blood. Because of these differences in duration of gestation and placental structure, comparisons among ungulates, rodents and primates must be made with caution.
In mice, classical MHC class I genes are transcribed in the spongiotrophoblast, towards the 'leading edge' of the trophoblast and, hence, are probably exposed to the maternal immune system (Philpott et al., 1988) . It is unclear whether non-classical murine class I genes are also expressed in the placenta (Hedley et al., 1989; Sipes et al., 1996) . Although there are relatively few data on tissue distribution of different class I products in the mouse placenta, recently developed transgenesis and gene knockout techniques have provided evidence that the mouse fetus may avoid immune destruction by controlling the maternal immune response rather than by reducing placental transplantation antigen expression. The mouse fetus suppresses maternal decidual lymphocytes that recognize paternally inherited MHC class I products (Munn et al., 1999) and deletes circulating lymphocytes producing antibody which binds to paternal MHC (Aït-Azzouzene et al., 1998) . Thus, short-term selective inhibition of maternal immunity may be an effective method for immunological protection of the fetus in species in which gestation is extremely short. Although the MHC locus of the rat is less well characterized than that of the mouse, enough data have been published to demonstrate that its placental immunology is very different. Both classical and non-classical class I loci are expressed in the rat placenta but, unlike mouse and human placental MHC, they are expressed in deeper, less 'exposed' regions of the fetal trophoblast (Kanbour et al., 1987) . MHC expression in the rat placenta is controlled in two unusual ways. First, some MHC class I genes are imprinted in the placenta so that only paternally inherited products are transcribed. Second, soon after fertilization, a developmental programme is initiated that prevents classical polymorphic class I molecules from reaching the surface of trophoblast cells, if they are not also present in maternal tissue. Because of these two processes, the rat placenta generates predominantly paternal MHC class I antigens but, of these, only the non-polymorphic non-classical antigens usually reach the cell surface (Kanbour-Shakir et al., 1990) . Thus, the rat placenta undergoes a specific and, at present, unique inactivation of the transplantation antigens most likely to induce maternal rejection.
Ungulates
In common with many ungulates, horses have a relatively non-invasive epitheliochorial placenta. Like the non-invasive regions of the human placenta, most equine trophoblast cells do not express MHC class I molecules. However, the chorionic girdle, which actively invades maternal tissue, expresses classical MHC class I genes inherited from both parents (Donaldson et al., 1990 (Donaldson et al., , 1994 . Thus, like the human fetus, the horse fetus increases transplantation antigen expression on cells as they become more exposed to the maternal immune system. However, unlike human trophoblast, equine invasive trophoblast expresses polymorphic classical MHC class I, and it is eventually subject to a maternal inflammatory immune reaction.
Pig trophoblast is entirely non-invasive and is not thought to express MHC antigens (Ramsoondar et al., 1999) .
As in horses, most bovine trophoblast cells are not invasive and do not express MHC antigens (Low et al., 1990; Ellis et al., 1998) . However, MHC class I is expressed on a subset of bovine trophoblast cells, the binucleate cells. These cells develop from uninucleate trophoblast cells and are extruded from the fetal to the maternal side of the placenta. As they develop, binucleate cells exhibit increased transcription of maternal and paternal classical class I mRNA and increased class I protein expression (Ellis et al., 1998; Bainbridge et al., 1999b 
Evolution of the placental transplant
Despite the anatomical differences between the placentas of the mammalian species studied, one surprising common feature has emerged. In many species, invasive trophoblast cells increase their expression of MHC transplantation antigens as they become more exposed to the maternal immune system. It is not surprising that non-invasive trophoblast switches off MHC expression, but why do so many species actively upregulate histocompatibility antigens again in invasive trophoblast? As yet, there is no answer to this question, but it deserves further investigation as the phenomenon is so phylogenetically widespread.
Invasive trophoblast cells may express transplantation antigens for several different reasons (Fig. 4) . First, MHC on trophoblast cells may help them adhere to and invade into maternal tissue. As trophoblast invasion is difficult to study in vitro, it is difficult to investigate this possibility experimentally. Second, trophoblasts isolated in a maternal environment may express MHC antigens to protect themselves from the maternal immune system. However, it is not clear how this process might occur. In species such as humans, rhesus monkeys and rats, in which invasive trophoblast expresses non-classical MHC class I, it can be argued that these unusual molecules suppress maternal immunity in the vicinity of the placenta. It is less easy to explain how the classical transplantation antigens on mouse, equine and bovine trophoblasts pacify the maternal immune system.
An extension of this idea is that MHC expression on trophoblast protects not just the invasive cell itself, but the entire fetoplacental unit. For example, the finding that HLA-G can suppress the proliferation of peripheral blood lymphocytes (Riteau et al., 1999) indicates a mechanism by which MHC molecules on invasive trophoblast may protect the human fetus.
Comparative placental immunology may help us further in understanding the challenges facing the eutherian fetus. Although placentation probably had a single evolutionary origin in eutherians, it has evolved many times in other vertebrates, most notably in marsupials, lizards and fish (Paulesu et al., 1995; Hamlett et al., 1999) . It may be instructive to see how these other groups have approached the problem of the fetal transplant.
A final question that arises from comparative studies of placental immunology is: why do all these eutherian species have different solutions to the same biological problem? One possible reason for the variation between different species is that some animals undergo long pregnancies while others undergo short pregnancies, and the duration of pregnancy may affect the immunological challenges facing the fetus. Studies in mice have shown that fetuses retained in utero for very short periods can evade maternal immunity by short-term modulation of maternal immune cells. In contrast, species with long pregnancies consistently exhibit unusual patterns of transplantation antigen expression on trophoblast. Thus, modulation of placental MHC expression may be the key to successful extended pregnancy.
The diversity of mammalian placental immunology may be explained further by the suggestion that the common ancestor of humans, horses and cattle had a short gestation period and that its fetuses survived in utero by short-term modulation of the maternal immune system. Because of this, all the long-gestation lineages descended from this ancestral species independently developed mechanisms to protect the fetus by regulating trophoblast antigens. This may be the reason why mammals have developed such a variety of approaches to overcome what is, after all, a problem common to them all.
